Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

OrganoClick AB (publ) publishes its interim report for Q1 2017

"After the first four months of the year I can conclude that we are on the right path. Q1, which historically has been one of our weakest periods, and has contributed with 18 % of the yearly revenue, has started well. Sales has increased from SEK 6.5 million to SEK 18.0 million which excluding our previous acquisition gave an organic sales growth of 52 %. The fixed operational costs for the group (excluding the acquired business) increased with only 2 % compared with Q1 2016. The gross margin increased to 37 % compared with 32 % the same period 2016 and March became the first month ever for

Honeywell and SKF launch Industrial Internet of Things pilot project

Gothenburg, 10 May  2017: Honeywell Process Solutions and SKF have launched a joint pilot project aimed at developing Industrial Internet of Things (IIoT) solutions. The pilot project, at a copper mine in Latin America, aims to create a digital standard for improved machine efficiency, reliability and competitiveness for industrial customers. As part of the pilot project, SKF’s expertise in bearings, lubrication and condition monitoring will be combined with Honeywell’s capabilities in data consolidation and software development. The project’s ambition is the joint development of a

Key executives in Diamyd Medical intend to subscribe in full for their shares in the rights issue

Diamyd Medical is implementing a rights issue totaling approximately MSEK 68.8 before issue costs, and an over-allotment option of MSEK 20. Key executives in the Company intend to subscribe in full for their shares in the issue. Chairman of the Board Erik Nerpin also intends to subscribe for additional units without the support of preferential rights. The total amount for the units to which key executives intend to subscribe is SEK 384,667.Erik Nerpin’s current holding totals 20,533 series B shares. Nerpin intends to invest SEK 100,000 in the rights issue as follows: in addition to

INVISIO’s US office is fully operational

Stockholm, May 10, 2017 INVISIO, a world-leading technology company developing innovative communications systems with hearing protection, today announced that its newly established US subsidiary is up and running and that the organization is expanding with new employees.INVISIO officially opened its US subsidiary in November 2016. INVISIO Communications Inc. is now completely operational and the organization is capable of efficiently targeting customers within security and defense throughout the United States. The key focus is to support existing customers, partners and programs,

Outokumpu’s MEUR 250 senior secured notes due 2021 – Voluntary partial redemption

Outokumpu OyjStock exchange releaseMay 10, 2017 at 9.30 am EETOutokumpu announced today the voluntary redemption of EUR 25 million related to its outstanding EUR 250 million senior secured notes due 2021 with 7.25% interest rate (OUTJO72521, ISIN code FI4000210646). Ten percent of the outstanding nominal amount of each note will be redeemed by Outokumpu on the redemption date of June 16, 2017 in accordance with the terms and conditions of the notes. The notes are listed on the Nasdaq Helsinki Ltd. As part of the Group’s cost reduction measures, the redemption of the notes will

STATEMENT BY THE INDEPENDENT BID COMMITTEE OF DIGNITA SYSTEMS AB (PUBL) IN RELATION TO 1A SMART START, LLC’S PUBLIC TAKEOVER OFFER

The Independent Bid Committee of the Board of Directors of Dignita Systems AB (publ) unanimously recommends the shareholders to accept the public takeover offer made by 1A Smart Start, LLC.Fairness opinion Background 1A Smart Start, LLC, ("Smart Start"), has today, through a press release, announced a public offer to the shareholders of Dignita Systems AB (publ), ("Dignita Systems"), to tender all shares in Dignita Systems for a consideration of SEK 11.30 in cash per share (the “Offer”). This statement is made by the

Archer Limited : Outlines strategy and outlook at Investor Day 2017

Hamilton, Bermuda (May 10, 2017) Archer Limited ("Archer") today presents the company strategy and financial outlook at its Investor Day 2017 held in Oslo, Norway. The company outlines its leading positions in selective segments of the oil services industry, an EBITDA margin target of 11% through the cycle, and the ambition of selective non-core divestments. Archer reiterates the short term guidance of a second quarter of 2017 in line with the first quarter, and a sequentially stronger second half of 2017. "Archer has been successful in turning around its operations and is currently

Archer Limited : PanAmerican Energy will award Archer a four year contract for drilling services in southern Argentina with an estimated contract value of NOK 6 billion

Hamilton, Bermuda  (May 10, 2017) Archer Limited ("Archer") announces that PanAmerican Energy («PanAmerican») will award Archer's subsidiary DLS Argentina Ltd. Surcusal a four-year contract for the provision of Drilling, Workover and Pulling Services for PanAmerican's Cerro Dragon field in the Golfo San Jorge basin in southern Argentina. Archer has provided Drilling, Workover and Pulling Services for PanAmerican since Archer's acquisition of the business in 2011 and the current contract reaffirms the two companies' commitment to production and further exploration in the Golfo San

Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

Proof of concept study of sequential ONCOS-102 then pembrolizumab treatment in patients with advanced melanoma refractory to check-point inhibitors Oslo 10 May 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the first patient has been recruited in the Company's ONCOS-102 study in advanced or unresectable melanoma patients who have had progression following checkpoint inhibitor. The study is conducted at Memorial Sloan Kettering Cancer Center in New York. Anne-

Etrion Releases First Quarter 2017 Results

May 10, 2017, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today released its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three months ended March 31, 2017.   Operational Highlights · Japan project development: Advanced on the development of the Kumamoto project in Japan with a total capacity of 45 megawatts (“MW”). Management expects to reach financial close for this backlog project in the fourth quarter of 2017. The Company is

AcadeMedia’s interim report July 2016 - March 2017

Third quarter (Jan 2017 – March 2017) · Net sales increased by 9.7 percent to SEK 2,540 million (2,316). · Operating profit (EBIT) decreased slightly to SEK 195 million (196). Adjusted for items affecting comparability, operating profit was SEK 197 million (199). · Net profit for the period was SEK 132 million (129). · Cash flow from operating activities amounted to SEK 123 million (128). · The average number of children and students in preschool, compulsory school and upper secondary school during the quarter was 66,299 (63,716), representing an increase of 4.1 percent.

Interim Report

January 1 – March 31, 2017The first quarter in figures · Net sales amounted to TSEK 1,755 (1,066). · The loss after tax amounted to TSEK 11,612 (11,600). · The loss per share amounted to SEK 1.40 (1.40). · The cash flow from current operations was negative in the amount of TSEK 11,981 (11,247). · The gross margin in the period was 26.5% (26.3%). Important events during the quarter · Our primary market Germany continues to show good growth with sales in value up by 99% and electrode sales volume up by 95% in the quarter. · Significant resources invested in the PMA

Notice to attend the Annual General Meeting of Shareholders of DDM Holding AG

The shareholders of DDM Holding AG (First North: DDM), (the “Company”), are hereby convened to the 2017 Annual General Meeting (the “AGM”) to be held on Wednesday, 31 May 2017 at 9:00 a.m. CEST, at the offices of Walder Wyss Ltd, Seefeldstr. 123, 8008 Zurich, Switzerland. The doors will open at 8:30 a.m. CEST.The shareholders are cordially invited to review the various ways to participate at the AGM and cast their vote. Detailed information on this and the agenda items can be found in the attached invitation to the AGM, also available on the Company’s website, http://ddm-group.ch/investors.

Nexam Chemical Holding AB (publ) Interim Financial Report 1 January – 31 March 2017

Solid base for growth in PET-foamFirst quarter at a glance Operational: · Supply agreement signed with Armacell regarding the NEXAMITE®-technology and related products for the production of PET-based foam. · Additional outsourcing concerning volume production of masterbatch at a new contract manufacturer. Financials: · Net sales for the first quarter totaled SEK 2,336,000 (816,000). · The operating loss for the firsts quarter SEK -4,933,000 (-4,706,000). · In comparison to the beginning of the year, cash and cash equivalents amounted to SEK 124,785,000 (133,147,000).

Wilson Therapeutics to host conference call to provide first quarter 2017 business update

On May 17, 2017, at 08:00 CET, Wilson Therapeutics will publish its interim report for the first quarter 2017. All interested parties are invited to participate in a web-cast telephone conference, which will include a presentation, on the same day at 10:00 CET. The event will be hosted by Wilson Therapeutics’ CEO Jonas Hansson and CFO Anders Martin-Löf, and the presentation will be held in English. How to participateThe live webcast and a recorded on-demand version including the presentation material will be accessible at: https://tv.streamfabriken.com/wilson-therapeutics-q1-2017.

INTERIM REPORT JANUARY – MARCH 2017

FIRST QUARTER ·  Net sales amounted to MSEK 139.3 (82.3), equivalent to an increase of 69.3%. Growth was mainly due to acquisitions. ·  EBITDA amounted to MSEK 43.7 (9.3), which corresponds to a margin of 31.4% (11.3%) ·  Cash flow from operating activities amounted to MSEK 34.9 (-61.0) ·  Earnings per share was SEK 0.29 (0.05) ·  Cash and cash equivalents and other short-term investments at the end of the period amounted to MSEK 166.1 (11.2) ·  A rights issue raised a total of MSEK 374 SIGNIFICANT EVENTS AFTER PERIOD END · Pfizer pays a milestone of MUSD 2 ·

Swedbank acquires PayEx

Swedbank acquires the payment provider PayEx. Through the acquisition Swedbank enters a new market and add services to meet customers’ needs of digital solutions for payments.The market for payment solutions has undergone major changes in recent years by greatly increased on-line purchases and development of invoicing solutions. Payment Service Providers (PSP), as PayEx, has been established with the purpose to improve the purchase experience. The acquisition creates good prerequisites to continue to develop long term and attractive payment solutions for retail businesses and its

AZ updates on tralokinumab trial in severe asthma

This announcement contains inside information   10 May 2017 07:00 BST ASTRAZENECA PROVIDES UPDATE ON STRATOS 1 PHASE III TRIAL OF TRALOKINUMAB IN SEVERE, UNCONTROLLED ASTHMA Tralokinumab did not meet its primary endpoint of a significant reduction in the annual asthma exacerbation rate Second pivotal Phase III trial STRATOS 2 is ongoing with results expected in second half of 2017     AstraZeneca and MedImmune, its global biologics research and development arm, today announced that tralokinumab, an anti-interleukin-13 (IL-13) human monoclonal antibody, did not meet its

1A SMART START, LLC ANNOUNCES A RECOMMENDED OFFER OF SEK 11.30 PER SHARE TO THE SHAREHOLDERS OF DIGNITA SYSTEMS AB

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or the United States or in any other jurisdictions where such offer pursuant to legislation and regulations in such relevant jurisdictions would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important notice” at the end of

Notice of an extraordinary general meeting

Notice is hereby served that an extraordinary general meeting of MPC Container Ships AS (the "Company") will be held on 18 May 2017 at 10.00 hours at the offices of Fearnley Business Management AS, Grev Wedels plass 9, 0151 Oslo, Norway. Agenda: 1. Election of a chairperson and a person to countersign the minutes 2. Approval of the notice and the agenda 3. Election of board of directors 4. Election of the auditor Shareholders who will attend the meeting (in person or by proxy) are requested to notify the Company of this by sending the attendance form to MPC CONTAINER SHIPS AS c/

Hexagon Composites ASA: Results for the first quarter 2017

In the first quarter 2017 Hexagon Composites generated NOK 346.2 (291.6) million in operating income and made an operating profit before depreciation (EBITDA) of NOK 35.1 (18.6) million. Operating profit (EBIT) was NOK 16.6 (3.2) million and profit/loss before tax came to NOK 6.3 (-2.6) million. The financial statements for the first quarter 2017 include the Group's fifty-percent share of Agility Fuel Solutions results accounted for under the equity method. In addition, the fully consolidated financial results of the acquired xperion Energy & Environment ("xperion") and related group

CXENSE ASA ANNOUNCES FIRST QUARTER 2017 RESULTS

OSLO, NORWAY – MAY 10, 2017 - CXENSE ASA TODAY REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDING MARCH 31, 2017. Highlights: · Data management and personalization revenue of USD 4.3 million, up 21% year-over-year · High Q1 churn driven by one large acquired video customer and continued decline of advertising portfolio · Q1 2017 group revenue of USD 5.9 million, down 5.5% year-over-year due to churn · EBITDA reflects continued investments in growth · Strategic investments in partners mporium and RepKnight to strengthen Cxense’s offering, distribution and sales ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top